Rules and Regulations. Notice of five AHRQ Subcommittee meetings
328 words·~1 min read·
/register/2021/12/08/2021-26545A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-90-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meetings AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of five AHRQ Subcommittee meetings. SUMMARY: The subcommittees listed below are part of AHRQ's Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will be closed to the public.
DATES: See below for dates of meetings: 1. *Healthcare Safety and Quality Improvement Research (HSQR)* Date: February 2-3, 2022 2. *Healthcare Effectiveness and Outcomes Research (HEOR)* Date: February 9-10, 2022 3. *Health System and Value Research (HSVR)* Date: February 10-11, 2022 4. *Healthcare Research Training (HCRT)* Date: February 24-25-28, 2022 5. *Healthcare Information Technology Research (HITR)* Date: February 24-25, 2022 ADDRESSES: Agency for Healthcare Research and Quality (Virtual Review), 5600 Fishers Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: (to obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.) Jenny Griffith, Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone
(301)427-1557. SUPPLEMENTARY INFORMATION: In accordance with section 10 (a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ's Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. Marquita Cullom, Associate Director. [FR Doc. 2021-26545 Filed 12-7-21; 8:45 am]
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Rules and Regulations
Notice of five AHRQ Subcommittee meetings
Cites 1Cited by 0 across 0 sources